Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Janusz Rolski Matthieu Rupin Wolfgang Eiermann Agnieszka Jagiello-Gruszfeld John R. Mackey E Alba Sara A Hurvitz Tadeusz Pieńkowski Louise Provencher Miguel Martin |
| Publication date | March 21, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |